The 11 analysts offering 1 year price forecasts for HAPV3F have a max estimate of — and a min estimate of —.
Analyst rating
Based on 11 analysts giving stock ratings to HAPV3F in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
HAPV3F EPS for the last quarter is 0.04 BRL despite the estimation of 0.03 BRL. In the next quarter EPS is expected to reach 0.05 BRL. Track more of HAPVIDA ON NM financials and stay on top of what is up with the company.
In the next quarter HAPVIDA ON NM revenue is expected to reach 7.33 B BRL. Check out HAPVIDA ON NM revenue and earnings and make informed decisions.
According to analysts, HAPV3F price target is 6.05 BRL with a max estimate of 7.00 BRL and a min estimate of 5.50 BRL. Check if this forecast comes true in a year, meanwhile watch HAPVIDA ON NM stock price chart and keep track of the current situation with HAPV3F news and stock market news.
We've gathered opinions of 11 analysts rating HAPV3F stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.